Efficacy and Vasodilatory Benefit of Magnesium Prophylaxis for Protection against Spinal Cord Ischemia

Annals of Vascular Surgery

Volumn 21, Issue 3, 2007, Pages 352-359

  Kohno, Hiroki ^a   Ishida, Atsushi ^a   Imamaki, Mizuho ^a   Shimura, Hitoshi ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA OCCLUSION; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG INFUSION; LASER DOPPLER FLOWMETRY; MALE; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; SPINAL CORD BLOOD FLOW; SPINAL CORD ISCHEMIA; VASODILATATION;

ANIMALS; AORTA, THORACIC; AORTIC DISEASES; ARTERIAL OCCLUSIVE DISEASES; BLOOD GAS ANALYSIS; DISEASE MODELS, ANIMAL; INFUSIONS, INTRA-ARTERIAL; LASER-DOPPLER FLOWMETRY; MAGNESIUM SULFATE; MALE; NEUROPROTECTIVE AGENTS; PARAPLEGIA; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SPINAL CORD; SPINAL CORD ISCHEMIA; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 34247622785     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2007.01.010     Document Type: Article

References (34)

1. Rokkas C.K., and Kouchoukos N.T. Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia; updated in 2001. Ann Thorac Surg 71 (2001) 1397-1398
2. Cho Y., Ueda T., Mori A., et al. Protective use of N-methyl-d-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity. J Vasc Surg 42 (2005) 765-771
3. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330 (1994) 613-622
4. de Haan P., Kalkman C.J., and Jacobs M.J. Pharmacologic neuroprotection in experimental spinal cord ischemia: a systematic review. J Neurosurg. Anesthesiol 13 (2001) 3-12
5. Muir K.W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol 6 (2006) 53-60
6. Sibai B.M. Magnesium sulfate prophylaxis in preeclampsia: evidence from randomized trials. Clin Obstet Gynecol 48 (2005) 478-488
7. Gowda R.M., and Khan I.A. Magnesium in treatment of acute myocardial infarction. Int J Cardiol 96 (2004) 467-469
8. Piotrowski A.A., and Kalus J.S. Magnesium for the treatment and prevention of atrial tachyarrhythmias. Pharmacotherapy 24 (2004) 879-895
9. Muir K.W., Lees K.R., Ford I., et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial. Lancet 363 (2004) 439-445
10. ++ protect against irreversible damage during CNS ischemia. Stroke 15 (1984) 695-698
11. Robertson C.S., Foltz R., Grossman R.G., et al. Protection against experimental ischemic spinal cord injury. Neurosurgery 64 (1986) 633-642
12. Lang-Lazdunski L., Heurteaux C., Dupont H., et al. Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole. J Vasc Surg 32 (2000) 179-189
13. 4 usage on spinal cord ischemia-reperfusion injury: electron microscopic and functional evaluation. Eur Surg Res 36 (2004) 20-25
14. Saeki H., Matsumoto M., Kaneko S., et al. Is intrathecal magnesium sulfate safe and protective against ischemic spinal cord injury in rabbits?. Anesth Analg 99 (2004) 1805-1812
15. Simpson J.I., Eide T.R., Schiff G.A., et al. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping. Anesthesiology 81 (1994) 1493-1499
16. Follis F., Miller K., Scremin O.U., et al. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model. Can J Neurol Sci 21 (1994) 227-232
17. 2+ of NMDA responses in spinal cord neurones. Nature 309 (1984) 261-263
18. Torimitsu K., Kasai N., and Furukawa Y. Effect of magnesium on neural activities in vitro. [in Japanese]. Clin. Calcium 14 (2004) 26-32
19. Chi O.Z., Pollak P., and Weiss H.R. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 304 (1990) 196-205
20. van den Bergh W.M., Dijkhuizen R.M., and Rinkel G.J. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 17 (2004) 301-313
21. Marsala M., and Yaksh T.L. Transient spinal ischemia in the rat: characterization of behavioral and histopathological consequences as a function of the duration of aortic occlusion. J Cereb Blood Flow Metab 14 (1994) 526-535
22. Miur K.W., and Less K.R. Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke 29 (1998) 913-923
23. Westermaier T., Hungerhuber E., Zausinger S., et al. Neuroprotective efficacy of intra-arterial and intravenous magnesium sulfate in a rat model of transient focal cerebral ischemia. Acta Neurochir (Wien) 145 (2003) 393-399
24. Huynh T.T., Miller III C.C., and Safi H.J. Delayed onset of neurologic deficit: significance and management. Semin Vasc Surg 13 (2000) 340-344
25. McKee J.A., Brewer R.P., Macy G.E., et al. Magnesium neuroprotection is limited in humans with acute brain injury. Neurocrit Care 2 (2005) 342-351
26. Kato H., Kanellopoulos G.K., Matsuo S., et al. Neuronal apoptosis and necrosis following spinal cord ischemia in the rat. Exp Neurol 148 (1997) 464-474
27. Lu K., Liang C.L., Chen H.J., et al. Injury severity and cell death mechanisms; effects of concomitant hypovolemic hypotension on spinal cord ischemia-reperfusion in rats. Exp Neurol 185 (2004) 120-132
28. Süzer T., Coskun E., Islekel H., et al. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Spinal Cord 37 (1999) 480-484
29. Kaptanoglu E., Beskonakli E., Solaroglu I., et al. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 26 (2003) 283-287
30. Solaroglu I., Kaptanoglu E., Okutan O., et al. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg Neurol 64 Suppl. 2 (2005) S17-S21
31. Teragawa H., Matsuura H., Chayama K., et al. Mechanisms responsible for vasodilation upon magnesium infusion in vivo: clinical evidence. Magnes Res 15 (2002) 241-246
32. Sheu J.R., Hsiao G., Shen M.Y., et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol 119 (2002) 1033-1041
33. Saris N.E., Mervaala E., Karppanen H., et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294 (2000) 1-26
34. Frerichs K.U., and Feuerstein G.Z. Laser-Doppler flowmetry. A review of its application for measuring cerebral and spinal cord blood flow. Mol Chem Neuropathol 12 (1990) 55-70